Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF – Get Free Report) will likely be announcing its resultson Thursday, November 12th. Analysts expect the company to post earnings of $0.0681 per share and revenue of $26.06 million for the quarter.
Surgical Science Sweden AB (publ) Price Performance
SUSRF opened at $5.47 on Tuesday. Surgical Science Sweden AB has a fifty-two week low of $3.95 and a fifty-two week high of $5.47. The business has a 50-day moving average of $5.29 and a 200-day moving average of $3.95.
About Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops simulation-based training and assessment solutions for medical professionals. Its products use virtual reality and other simulation technologies to help users practise surgical techniques in a controlled environment.
The company’s offerings cover areas including laparoscopic, endoscopic and robotic surgery, as well as other clinical skills. Surgical Science serves hospitals, universities and medical-device companies, and works with industry partners to incorporate simulation and training tools into their products and education programs.
Founded in Sweden in 1999, the company serves customers internationally.
Further Reading
- Five stocks we like better than Surgical Science Sweden AB (publ)
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
